Natco Pharma v FMC Corp IPR case: Supreme Court transfers patent infringement suits to Delhi High Court
The intellectual property rights case is over a patent on the compound Chlorantraniliprole (CTPR), for which the two parties have been litigating before the Delhi High Court since 2022.
The Supreme Court recently transferred the patent infringement suits filed by FMC Corporation against Natco Pharma LIMITED to the Delhi High Court. (Natco Pharma Limited v. FMC Corporation and ors)